SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-076241
Filing Date
2023-09-13
Accepted
2023-09-13 09:01:12
Documents
13
Period of Report
2023-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185104-8k_abvcbio.htm   iXBRL 8-K 28069
2 LETTER AGREEMENT ea185104ex10-1_abvcbio.htm EX-10.1 8966
  Complete submission text file 0001213900-23-076241.txt   211947

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abvc-20230913.xsd EX-101.SCH 3021
4 XBRL LABEL FILE abvc-20230913_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abvc-20230913_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea185104-8k_abvcbio_htm.xml XML 3218
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231251691
SIC: 2834 Pharmaceutical Preparations